Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Ovarian Neoplasms 29Fallopian Tube Neoplasms 15Breast Neoplasms 10Carcinoma, Ovarian Epithelial 6Peritoneal Neoplasms 3Multiple Myeloma 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Neoplasms 2Neoplasm Metastasis 2Lymphoma, T-Cell, Peripheral 2Lymphoma, Large B-Cell, Diffuse 2Vaccinia 1Uterine Cervical Neoplasms 1Sarcoma, Kaposi 1Pelvic Neoplasms 1Neoplasms, Plasma Cell 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Low Grade Serous Ovarian Cancer 1Leukemia, Lymphocytic, Chronic, B-Cell 1Genital Neoplasms, Female 1Genetic Predisposition to Disease 1Endometrial Neoplasms 1Carcinoma 1Acquired Immunodeficiency Syndrome 1AIDS-related Kaposi sarcoma 1

Interventions

pembrolizumab 95Cisplatin 35Paclitaxel 27Carboplatin 27Docetaxel 17lenvatinib 15Fluorouracil 14Saline Solution 13Capecitabine 12Pemetrexed 10Gemcitabine 10Oxaliplatin 9Cetuximab 7Albumin-Bound Paclitaxel 7olaparib 6epacadostat 6Bevacizumab 6130-nm albumin-bound paclitaxel 6Leucovorin 5enzalutamide 4Etoposide 4trifluridine tipiracil drug combination 3regorafenib 3belzutifan 3Prednisone 3Irinotecan 3Glucose 3Dexamethasone 3liposomal doxorubicin 2durvalumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × Parkinson Disease 4, Autosomal Dominant Lewy Body × liposomal doxorubicin × Clear all
NCT06312176 2026-05-22

MK-2870-010

Merck Sharp & Dohme LLC

Phase 3 Recruiting
1,200 enrolled
Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Breast Neoplasms

NCT04895358 2026-03-11

KEYNOTE-B49

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
340 enrolled
Breast

Parkinson Disease 4, Autosomal Dominant Lewy Body, Breast Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡